Gadolinium-based contrast agents (GBCAs) form the cornerstone of current primary brain
tumor MRI protocols at all stages of the patient journey. Though an imperfect measure of …

This AJR Expert Panel Narrative Review explores the current status of advanced MRI and
PET techniques for the posttherapeutic response assessment of high-grade adult-type …

The precise assessment of vascular heterogeneity in brain tumors is vital for diagnosing,
grading, predicting progression, and guiding treatment decisions. However, currently, there …

Brain tumor diagnosis using MRI scans poses significant challenges due to the complex
nature of tumor appearances and variations. Traditional methods often require extensive …

Dynamic-susceptibility-contrast perfusion-weighted-imaging (DSC-PWI) is an MRI technique
that provides non-invasive in vivo assessment of microvascular environments. It consists of a …

Abstract The 2021 World Health Organization classification of CNS tumours was greeted
with enthusiasm as well as an initial potential overwhelm. However, with time and …

Global agreement in central nervous system (CNS) tumor classification is essential for
predicting patient prognosis and determining the correct course of treatment, as well as for …

Objective Presurgical differentiation between astrocytomas and oligodendrogliomas
remains an unresolved challenge in neuro-oncology. This research aims to provide a …

ABSTRACT Introduction Lower-grade (grade 2–3) gliomas (LGGs) constitutes a group of
primary brain tumors with variable clinical behaviors and treatment responses. Recent …

Glioma is the most common type of primary malignant tumor of the central nervous system
(CNS), and is characterized by high malignancy, high recurrence rate and poor survival …